APIM050292: AVN944
CAS No.: 297730-17-7.
Purity: >99.5% chem and stereomerical purity (HPLC and Chiral HPLC at 214 and 254 nm).
QC: HPLC-MS, 1HNMR, Chiral HPLC and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO.One-stop sequence optimization, gene synthesis, and DNA subcloning services.
Various bacterial expression vectors developed by ourselves or our partners.Fast turnaround: 6-7 weeks.
We have a lot of experience in dealing with difficult-to-express proteins.
While the success rate of stable cell line generation is highly dependent on the target genes and Syd Labs can not guarantee 100% success rate, our in-house data show a success rate greater than 90%.BP003060: Biotinylated Recombinant Human ACE2-His-Avi Protein (rhACE2-His)
Source: mammalian cells.
Activity: Immobilized recombinant SARS-CoV-2 (2019-nCoV) Spike S RBD at 1 ug/ml (100 ul/well). Dose response curve for the biotinylated recombinant human ACE2 protein with the EC50 of 0.1 ug/ml determined by ELISA.
Purity: > 95% by PAGE under reduced condition, and SEC-HPLC.Custom Ilama and alpaca monoclonal antibody development (VHH, sdAb or nanobody) by Ilama or alpaca immunization and phage display screening.
Production of camel, Ilama or alpaca VHH in E.coli or VHH-Fc in HEK 293 cells.
Fast turnaround: 4-6 months once the antigen is available.Capillary electrophoresis (CE) analysis using Caliper LC90.
Sample requirement: 50-100 ug.
Fast turnaround time: 1 - 2 weeks.Capillary isoelectric focusing is an analytical technique for characterization of protein mixtures and determination of protein isoelectric points.
Sample requirement: 50-100 ug.
Fast turnaround time: 1 - 2 weeks.Experienced scientists working on antigen and antibody production, antibody engineering, lentivirus, and cell line development services for decades. >90% success rate of stable cell line generation.
Fast turnaround:
Antigen (peptide or protein) production: 3-6 weeks.
Mouse monoclonal antibody production: 20-24 weeks.
Screening phage or yeast libraries for fully human antibodies: 8-12 weeks.
Sequencing hybrioma antibody: 1-3 weeks.
Chimeric antibody production: 3-4 weeks.
Antibody humanization: 8-10 weeks.
Construction of CAR cassette, lentivirus packaging and production: 4-5 weeks.
T-cell activation, transduction, and CAR T-cell expansion: 4-5 weeks.
Confirmation of CAR expression, IFN-gamma ELISA, and cytotoxicity assay of transduced and expanded T-cells: 2 weeks.BP001012-CYT-654: Recombinant Rat CNTF Ciliary Neurotrophic Factor (CNTF) Protein
Source: E. coli-derived.
Fully biologically active by its ability to phosphorylate STAT3 in several cells lines.
Purity: > 99% by SDS-PAGE and Gel Filtration.- Any gene;
- Any host cell, including primary cell;
- Highly efficient and precise.
Fast turnaround:
Knock-out cell line generation: 16-19 weeks.
Knock-in cell line generation: 20-24 weeks.De novo antibody sequencing to obtain the intact amino acid sequence of variable and/or constant regions of monoclonal antibodies by LC-MS/MS.
Sample requirement: 3-5 mg at 1 mg/ml preferred (minimum: 2 mg at 1 mg/mL).
Fast turnaround time: 2-3 months per antibody, but may require more time depending on the complexity of analysis.